SOST and chronic myelogenous leukemia, BCR-ABL1 positive: Additionally, a study revealed significant positive correlations between CML and serum levels of sclerostin and fibroblast growth factor 23 (FGF23), both of which are secreted by osteocytes and known to impair bone mineralization [43].